Intellectual Property Disputes Intellectual Property Disputes

German and U.K. courts diverge on whether AI models infringe copyright  

When it comes to AI and copyright, recent rulings show there is no global consensus on whether training models infringe.

Stability AI successfully defends Getty Images’ U.K. copyright infringement claim

The U.K. High Court has ruled that a generative AI tool that creates high-quality images from text descriptions, is not an “infringing article”.

The trademark four(mula): enforcement and risk mitigation

Without proper enforcement, businesses run the risk of losing the distinctiveness of their trademarks and the scope of protection they afford.

Avoiding IP quicksand: lessons from ITP SA v. CNOOC Petroleum North America ULC

The decision serves as a reminder of the potential consequences of failing to manage IP diligently within large infrastructure projects.

Changes to Canadian trademark laws and practice coming April 1, 2025

We examine the amendments to the Trademarks Act and Trademarks Regulations coming into force on April 1, 2025, and their practical implications.

Presenting our Legal Outlook

Osler Legal Outlook provides a look back on key legal developments in 2024 and a look forward to the implications for 2025 and beyond.

U.K. appellate court rules artificial neural network application is not patent-eligible subject matter

Although artificial neural networks (ANNs) have evolved to increasingly form the backbone of modern commerce, their patentability remained...

Canadian Intellectual Property Office (CIPO) increasing official fees effective January 1, 2024

CIPO is set to substantially increase official fees for patents, trademarks, industrial designs and copyrights on January 1, 2024.

Overbroad patent claims: Canadian law may draw strength from policy behind U.S. and U.K. Supreme Court rulings

A recent U.S. Supreme Court decision serves as a reminder that a bargain underlies the issuance of a patent and that an applicant must fully and...

PMPRB releases long-awaited draft guidelines regarding excessive drug pricing under new regime

The Patented Medicine Prices Review Board (PMPRB) has updated its approach to excessive pricing. Osler’s Nathaniel Lipkus and Yael Mansour discuss...